A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/41 (2006.01) A61K 9/20 (2006.01) A61K 47/32 (2006.01) A61K 47/38 (2006.01)
Patent
CA 2622805
The invention is directed to compressed tablets comprising valsartan, microcrystalline cellulose and optionally crospovidone. The weight ratio of the valsartan to the microcrystalline cellulose is from 2:1 to 0.3:1. The microcrystalline cellulose can comprise more than 30% by weight based on total weight of the core of the tablet. The tablet is an oral dosage form for administration of the valsartan.
L'invention porte sur des comprimés ayant subi une compression contenant le valsartan, de la cellulose microcristalline et, facultativement, de la crospovidone. Le ratio en poids du valsartan sur la cellulose microcristalline est de 2:1 à 0,3:1. Le poids de la cellulose microcristalline peut correspondre à plus de 30 % du poids total du comprimé. Le comprimé est la forme posologique du valsartan à prendre par voie orale.
Bullock Gillian Rosemary
de Gasparo Marc
Ganter Sabina Maria
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Compressed tablets comprising valsartan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compressed tablets comprising valsartan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compressed tablets comprising valsartan will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1986134